Details for New Drug Application (NDA): 071484
✉ Email this page to a colleague
NDA 071484 describes VINCRISTINE SULFATE PFS, which is a drug marketed by Hospira and Teva Pharms Usa and is included in two NDAs. It is available from one supplier. Additional details are available on the VINCRISTINE SULFATE PFS profile page.
The generic ingredient in VINCRISTINE SULFATE PFS is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.
The generic ingredient in VINCRISTINE SULFATE PFS is vincristine sulfate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vincristine sulfate profile page.
Summary for 071484
| Tradename: | VINCRISTINE SULFATE PFS |
| Applicant: | Hospira |
| Ingredient: | vincristine sulfate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 071484
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VINCRISTINE SULFATE PFS | vincristine sulfate | INJECTABLE;INJECTION | 071484 | ANDA | Hospira, Inc. | 61703-309 | 61703-309-25 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-309-25) / 2 mL in 1 VIAL, SINGLE-DOSE |
| VINCRISTINE SULFATE PFS | vincristine sulfate | INJECTABLE;INJECTION | 071484 | ANDA | Hospira, Inc. | 61703-309 | 61703-309-26 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-309-26) / 1 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
| Approval Date: | Apr 19, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
